Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-16

Clinical Trial Update: Ketamine + Magnesium for Chronic Cluster Headache (KETALGIA) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial (KETALGIA) is investigating ketamine plus magnesium for refractory chronic cluster headache and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)
  • Magnesium sulfate (magnesium sulfate)

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Refractory Chronic Cluster Headache | Phase 4 | Status: RECRUITING